• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌幸存者老龄化过程中的生活质量与性健康

Quality of Life and Sexual Health in the Aging of PCa Survivors.

作者信息

Gacci Mauro, Baldi Elisabetta, Tamburrino Lara, Detti Beatrice, Livi Lorenzo, De Nunzio Cosimo, Tubaro Andrea, Gravas Stavros, Carini Marco, Serni Sergio

机构信息

Department of Urology, University of Florence, Careggi Hospital, Viale Gramsci 7, 50121 Florence, Italy.

Department of Experimental and Clinical Biomedical Sciences, Section of Clinical Pathophysiology, University of Florence, Italy.

出版信息

Int J Endocrinol. 2014;2014:470592. doi: 10.1155/2014/470592. Epub 2014 Mar 17.

DOI:10.1155/2014/470592
PMID:24744780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3976934/
Abstract

Prostate cancer (PCa) is the most common malignancy in elderly men. The progressive ageing of the world male population will further increase the need for tailored assessment and treatment of PCa patients. The determinant role of androgens and sexual hormones for PCa growth and progression has been established. However, several trials on androgens and PCa are recently focused on urinary continence, quality of life, and sexual function, suggesting a new point of view on the whole endocrinological aspect of PCa. During aging, metabolic syndrome, including diabetes, hypertension, dyslipidemia, and central obesity, can be associated with a chronic, low-grade inflammation of the prostate and with changes in the sex steroid pathways. These factors may affect both the carcinogenesis processes and treatment outcomes of PCa. Any treatment for PCa can have a long-lasting negative impact on quality of life and sexual health, which should be assessed by validated self-reported questionnaires. In particular, sexual health, urinary continence, and bowel function can be worsened after prostatectomy, radiotherapy, or hormone treatment, mostly in the elderly population. In the present review we summarized the current knowledge on the role of hormones, metabolic features, and primary treatments for PCa on the quality of life and sexual health of elderly Pca survivors.

摘要

前列腺癌(PCa)是老年男性中最常见的恶性肿瘤。全球男性人口的老龄化进程将进一步增加对前列腺癌患者进行个性化评估和治疗的需求。雄激素和性激素在前列腺癌生长和进展中的决定性作用已得到证实。然而,最近几项关于雄激素与前列腺癌的试验聚焦于尿失禁、生活质量和性功能,这为前列腺癌整个内分泌学方面提供了新的视角。在衰老过程中,包括糖尿病、高血压、血脂异常和中心性肥胖在内的代谢综合征可能与前列腺的慢性低度炎症以及性类固醇途径的变化有关。这些因素可能会影响前列腺癌的致癌过程和治疗结果。前列腺癌的任何治疗都可能对生活质量和性健康产生长期负面影响,这应该通过经过验证的自我报告问卷进行评估。特别是,前列腺切除术后、放疗或激素治疗后,性健康、尿失禁和肠道功能可能会恶化,这在老年人群中尤为常见。在本综述中,我们总结了目前关于激素、代谢特征以及前列腺癌的主要治疗方法对老年前列腺癌幸存者生活质量和性健康影响的相关知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d7/3976934/39617f2ff58e/IJE2014-470592.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d7/3976934/4f2b629baf15/IJE2014-470592.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d7/3976934/5cb9d6c61c2f/IJE2014-470592.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d7/3976934/39617f2ff58e/IJE2014-470592.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d7/3976934/4f2b629baf15/IJE2014-470592.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d7/3976934/5cb9d6c61c2f/IJE2014-470592.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d7/3976934/39617f2ff58e/IJE2014-470592.003.jpg

相似文献

1
Quality of Life and Sexual Health in the Aging of PCa Survivors.前列腺癌幸存者老龄化过程中的生活质量与性健康
Int J Endocrinol. 2014;2014:470592. doi: 10.1155/2014/470592. Epub 2014 Mar 17.
2
Impact of Prostate Cancer Treatment on the Sexual Quality of Life for Men-Who-Have-Sex-with-Men.前列腺癌治疗对男男性行为者性生活质量的影响。
J Sex Med. 2015 Dec;12(12):2378-86. doi: 10.1111/jsm.13030. Epub 2015 Nov 4.
3
Description of Surgical Technique and Oncologic and Functional Outcomes of the Precision Prostatectomy Procedure (IDEAL Stage 1-2b Study).精准前列腺切除术(IDEAL 分期 1-2b 研究)的手术技术描述及肿瘤学和功能学结果。
Eur Urol. 2022 Apr;81(4):396-406. doi: 10.1016/j.eururo.2021.10.017. Epub 2021 Dec 4.
4
A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.一项针对前列腺癌根治性治疗候选者的不良事件和全球生活质量的全国性研究。
BJU Int. 2013 Feb;111(2):221-32. doi: 10.1111/j.1464-410X.2012.11198.x. Epub 2012 Jun 6.
5
A randomized comparison of group mindfulness and group cognitive behavioral therapy vs control for couples after prostate cancer with sexual dysfunction.一项针对前列腺癌后性功能障碍的夫妇的随机比较研究,比较了团体正念和团体认知行为疗法与对照组的效果。
J Sex Med. 2023 Feb 27;20(3):346-366. doi: 10.1093/jsxmed/qdac038.
6
Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men with Heterosexual Men.前列腺癌后的健康相关生活质量、心理困扰及性变化:男同性恋和双性恋男性与异性恋男性的比较
J Sex Med. 2016 Mar;13(3):425-34. doi: 10.1016/j.jsxm.2015.12.026. Epub 2016 Feb 4.
7
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.高风险局限性和局部进展性前列腺癌的主要治疗方法的获益与风险:一项国际多学科系统评价。
Eur Urol. 2020 May;77(5):614-627. doi: 10.1016/j.eururo.2020.01.033. Epub 2020 Mar 4.
8
Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.局限性前列腺癌初始治疗后的长期健康相关生活质量:来自 CaPSURE 登记处的结果。
Eur Urol. 2015 Oct;68(4):600-8. doi: 10.1016/j.eururo.2014.08.074. Epub 2014 Sep 18.
9
A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.一项关于接受主动监测或放射治疗的低风险前列腺癌患者健康相关生活质量结局的前瞻性研究。
Urol Oncol. 2017 May;35(5):234-242. doi: 10.1016/j.urolonc.2016.12.015. Epub 2017 Jan 19.
10
The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.老年前列腺癌幸存者的尿失禁和排尿困扰负担。
Eur Urol. 2013 Oct;64(4):672-9. doi: 10.1016/j.eururo.2013.03.041. Epub 2013 Apr 3.

引用本文的文献

1
Latest Evidence on Post-Prostatectomy Urinary Incontinence.前列腺切除术后尿失禁的最新证据
J Clin Med. 2023 Feb 2;12(3):1190. doi: 10.3390/jcm12031190.
2
Clinical Effects of Jiawei Danggui Beimu Kushen Pills in the Treatment of Prostate Cancer and Their Influence on the Expression of Serum Prostate Specific Antigen.加味当归贝母苦参丸治疗前列腺癌的临床疗效及其对血清前列腺特异性抗原表达的影响
Evid Based Complement Alternat Med. 2021 Nov 22;2021:1036068. doi: 10.1155/2021/1036068. eCollection 2021.
3
Impact of Age on Patient-Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer.

本文引用的文献

1
Androgens and prostate cancer; pathogenesis and deprivation therapy.雄激素与前列腺癌;发病机制与去势治疗。
Best Pract Res Clin Endocrinol Metab. 2013 Aug;27(4):603-16. doi: 10.1016/j.beem.2013.05.001. Epub 2013 Jun 5.
2
Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.雄激素受体(AR)在前列腺癌细胞死亡中的阳性和阴性作用,包括细胞凋亡、失巢凋亡、侵入、坏死和自噬性细胞死亡。
Cancer Treat Rev. 2014 Feb;40(1):31-40. doi: 10.1016/j.ctrv.2013.07.008. Epub 2013 Aug 7.
3
Long-term survival of participants in the prostate cancer prevention trial.
年龄对前列腺癌立体定向体部放射治疗后患者报告结局的影响。
Cureus. 2021 Mar 9;13(3):e13780. doi: 10.7759/cureus.13780.
4
Impact of Obesity on Long-Term Urinary Incontinence after Radical Prostatectomy: A Meta-Analysis.肥胖对根治性前列腺切除术后长期尿失禁的影响:一项荟萃分析。
Biomed Res Int. 2018 Apr 3;2018:8279523. doi: 10.1155/2018/8279523. eCollection 2018.
5
Racial disparities in prostate cancer: a molecular perspective.种族差异与前列腺癌:分子视角
Front Biosci (Landmark Ed). 2017 Jan 1;22(5):772-782. doi: 10.2741/4515.
6
The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery.中心性肥胖对前列腺手术后储尿期下尿路症状及尿失禁的影响
Curr Urol Rep. 2016 Sep;17(9):61. doi: 10.1007/s11934-016-0620-4.
7
Surgery and hormonal treatment for prostate cancer and sexual function.前列腺癌的手术及激素治疗与性功能
Transl Androl Urol. 2015 Apr;4(2):103-9. doi: 10.3978/j.issn.2223-4683.2015.01.13.
8
Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?在活检标本中评估的生物标志物能否预测前列腺癌的侵袭性?
J Cancer Res Clin Oncol. 2016 Jan;142(1):201-12. doi: 10.1007/s00432-015-2015-1. Epub 2015 Jul 26.
前列腺癌预防试验参与者的长期生存情况。
N Engl J Med. 2013 Aug 15;369(7):603-10. doi: 10.1056/NEJMoa1215932.
4
[Role of androgen in the elderly. Problems of androgen deprivation therapy].[雄激素在老年人中的作用。雄激素剥夺治疗的问题]
Clin Calcium. 2013 Aug;23(8):1185-90.
5
Androgen receptors in hormone-dependent and castration-resistant prostate cancer.雄激素受体在激素依赖性和去势抵抗性前列腺癌中的作用。
Pharmacol Ther. 2013 Dec;140(3):223-38. doi: 10.1016/j.pharmthera.2013.07.003. Epub 2013 Jul 13.
6
Role of abdominal obesity for functional outcomes and complications in men treated with radical prostatectomy for prostate cancer: results of the Multicenter Italian Report on Radical Prostatectomy (MIRROR) study.腹型肥胖在接受前列腺癌根治术的男性患者功能结局及并发症中的作用:多中心意大利前列腺癌根治术报告(MIRROR)研究结果
Scand J Urol. 2014 Apr;48(2):138-45. doi: 10.3109/21681805.2013.803151. Epub 2013 Jun 19.
7
Management of prostate cancer in elderly men.老年男性前列腺癌的管理。
Semin Radiat Oncol. 2013 Jul;23(3):198-205. doi: 10.1016/j.semradonc.2013.01.007.
8
An androgen receptor N-terminal domain antagonist for treating prostate cancer.一种用于治疗前列腺癌的雄激素受体 N 端结构域拮抗剂。
J Clin Invest. 2013 Jul;123(7):2948-60. doi: 10.1172/JCI66398. Epub 2013 Jun 3.
9
Developments in external beam radiotherapy for prostate cancer.前列腺癌的体外放射治疗进展。
Urology. 2013 Jul;82(1):5-10. doi: 10.1016/j.urology.2013.03.043. Epub 2013 May 21.
10
Recurrent gene fusions in prostate cancer: their clinical implications and uses.前列腺癌中基因重排的复发:其临床意义及用途。
Curr Urol Rep. 2013 Jun;14(3):214-22. doi: 10.1007/s11934-013-0321-1.